Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance
出版年份 2018 全文链接
标题
Pharmacological Insights into the Use of Apomorphine in Parkinson’s Disease: Clinical Relevance
作者
关键词
-
出版物
CLINICAL DRUG INVESTIGATION
Volume 38, Issue 4, Pages 287-312
出版商
Springer Nature
发表日期
2018-01-12
DOI
10.1007/s40261-018-0619-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Activation of Glutathione Peroxidase and Inhibition of p53-Related Apoptosis by Apomorphine
- (2018) Linqing Ma et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study
- (2017) Thomas E. Kimber et al. INTERNAL MEDICINE JOURNAL
- Continuous subcutaneous apomorphine infusion in advanced Parkinson’s disease: 10-year experience with 230 patients
- (2017) Ángel Sesar et al. JOURNAL OF NEUROLOGY
- Personalized medicine in Parkinson's disease: Time to be precise
- (2017) Nataliya Titova et al. MOVEMENT DISORDERS
- Apomorfina en bomba de perfusión continua en pacientes con enfermedad de Parkinson avanzada con diferente grado de afectación funcional
- (2017) G. Salazar et al. NEUROLOGIA
- Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study
- (2017) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Challenges and trends in apomorphine drug delivery systems for the treatment of parkinson's disease
- (2017) Nrupa Borkar et al. Asian Journal of Pharmaceutical Sciences
- A Protocol for Induction of Tolerance to Apomorphine in Patients With Parkinson Disease and Hypersensitivity to Apomorphine
- (2016) D Gutiérrez-Fernández et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Parkinson’s: a syndrome rather than a disease?
- (2016) Nataliya Titova et al. JOURNAL OF NEURAL TRANSMISSION
- Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study
- (2016) Sophie Drapier et al. JOURNAL OF NEUROLOGY
- Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
- (2016) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- The efficacy of apomorphine – A non-motor perspective
- (2016) Miguel Rosa-Grilo et al. PARKINSONISM & RELATED DISORDERS
- Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therapy
- (2016) Roongroj Bhidayasiri et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine therapy in Parkinson's disease and future directions
- (2016) Nataliya Titova et al. PARKINSONISM & RELATED DISORDERS
- Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients
- (2016) Robbert W.K. Borgemeester et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine - pharmacological properties and clinical trials in Parkinson's disease
- (2016) Peter Jenner et al. PARKINSONISM & RELATED DISORDERS
- Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson’s Disease: The APO-NIGHT Study
- (2016) Gustavo Fernández-Pajarín et al. Journal of Parkinsons Disease
- Role of Apomorphine in the Treatment of Parkinson’s Disease
- (2015) Allison Boyle et al. CNS DRUGS
- Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
- (2015) Alison J. Yarnall et al. MOVEMENT DISORDERS
- Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations
- (2015) Claudia Trenkwalder et al. PARKINSONISM & RELATED DISORDERS
- Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program
- (2015) P. Odin et al. PARKINSONISM & RELATED DISORDERS
- The role of subcutaneous infusion of apomorphine in Parkinson’s disease
- (2014) Karoline Wenzel et al. Expert Review of Neurotherapeutics
- Treatment of camptocormia with continuous subcutaneous infusions of apomorphine: 1-year prospective pilot study
- (2014) Katerina Mensikova et al. JOURNAL OF NEURAL TRANSMISSION
- EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- (2014) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Apomorphine attenuates ethanol-induced neurodegeneration in the adult rat cortex
- (2014) Haroon Badshah et al. NEUROCHEMISTRY INTERNATIONAL
- Le traitement par apomorphine en perfusion continue sous-cutanée dans la maladie de Parkinson : analyse rétrospective d’une série de 81 patients
- (2014) M. Rambour et al. REVUE NEUROLOGIQUE
- Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s disease in the UK and Germany
- (2014) Evelyn Walter et al. JOURNAL OF MEDICAL ECONOMICS
- Inhaled dry powder apomorphine (VR040) for ‘off ’ periods in Parkinson's disease: an in-clinic double-blind dose ranging study
- (2013) K. A. Grosset et al. ACTA NEUROLOGICA SCANDINAVICA
- Protective Effects of Apomorphine against Zinc-Induced Neurotoxicity in Cultured Cortical Neurons
- (2013) Hirokazu Hara et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Major eosinophilia induced by subcutaneous apomorphine infusion: four cases
- (2013) X. Moisset et al. EUROPEAN JOURNAL OF NEUROLOGY
- Subcutaneous infusions of apomorphine: a reappraisal of its therapeutic efficacy in advanced Parkinson’s disease
- (2013) Francisco Grandas Expert Review of Neurotherapeutics
- Acute genital pain during non-motor fluctuations improved by apomorphine
- (2013) Romain Lefaucheur et al. MOVEMENT DISORDERS
- Subcutaneous apomorphine and non-motor symptoms in Parkinson's disease
- (2013) Antoniya Todorova et al. PARKINSONISM & RELATED DISORDERS
- Dopamine Transporter Genotype Dependent Effects of Apomorphine on Cold Pain Tolerance in Healthy Volunteers
- (2013) Roi Treister et al. PLoS One
- Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
- (2013) Luca Passamonti et al. Brain and Behavior
- The Pharmacological Properties and Therapeutic Use of Apomorphine
- (2012) Samo Ribarič MOLECULES
- Multiple subcutaneous abscesses and necroses due to apomorphine pump treatment
- (2012) Lars Wojtecki et al. PARKINSONISM & RELATED DISORDERS
- Attempted suicide under high dose dopaminergic therapy including apomorphine
- (2012) Walter Struhal et al. WIENER KLINISCHE WOCHENSCHRIFT
- Pharmacologic Safety Concerns in Parkinson's Disease: Facts and Insights
- (2011) Jack J. Chen INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Continuous drug delivery in early- and late-stage Parkinson’s disease as a strategy for avoiding dyskinesia induction and expression
- (2011) P. Jenner et al. JOURNAL OF NEURAL TRANSMISSION
- Apomorphine-induced necrotic ulcers
- (2011) Jeban Ganesalingam et al. MOVEMENT DISORDERS
- The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease
- (2011) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Apomorphine infusion in advanced Parkinson’s patients with subthalamic stimulation contraindications
- (2011) Sophie Drapier et al. PARKINSONISM & RELATED DISORDERS
- Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome
- (2010) I. Reuter et al. ACTA NEUROLOGICA SCANDINAVICA
- Nécroses cutanées localisées aux points d’injection d’apomorphine
- (2010) A. Dadban et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation
- (2010) Eri Himeno et al. ANNALS OF NEUROLOGY
- Allergic contact dermatitis caused by apomorphine hydrochloride in a carer
- (2010) J. Garcia-Gavin et al. CONTACT DERMATITIS
- Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients
- (2010) M. Lafreniere-Roula et al. EXPERIMENTAL NEUROLOGY
- A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation
- (2010) Angelo Antonini et al. JOURNAL OF NEUROLOGY
- Apomorphine effect on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
- (2010) Estelle Dellapina et al. MOVEMENT DISORDERS
- Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids
- (2010) Kaisa A. Salminen et al. PHYTOMEDICINE
- The Effects of Apomorphine on Visual Perception in Patients With Parkinson Disease and Visual Hallucinations
- (2009) Linda Geerligs et al. CLINICAL NEUROPHARMACOLOGY
- The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease
- (2009) Julia Vaamonde et al. MOVEMENT DISORDERS
- Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations
- (2009) Teus van Laar et al. PARKINSONISM & RELATED DISORDERS
- Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
- (2008) Pedro J. García Ruiz et al. MOVEMENT DISORDERS
- Ultrasound treatment of cutaneous side-effects of infused apomorphine: A randomized controlled pilot study
- (2008) Leon Poltawski et al. MOVEMENT DISORDERS
- Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures
- (2008) Francesca Vaglini et al. NEUROPHARMACOLOGY
- Recurrent atrial fibrillation after subcutaneous apomorphine
- (2007) Gianluca Ardolino et al. PARKINSONISM & RELATED DISORDERS
- Apomorphine for the acute treatment of “off” episodes in Parkinson's disease
- (2007) Mark Stacy et al. PARKINSONISM & RELATED DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started